Troponin not just a simple cardiac marker: Prognostic significance of cardiac troponin

Chinese Medical Journal

Volumn 122, Issue 3, 2009, Pages 351-358

  Setiadi, Benny Mulyanto ^a   Lei, Han ^a   Chang, Jing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Cardiac troponin; Prognostic; Risk stratification; Troponin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; FIBRINOGEN RECEPTOR ANTAGONIST; STREPTOKINASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; TRIMETAZIDINE; TROPONIN; TROPONIN I; TROPONIN T;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DEATH; DISEASE MARKER; FORWARD HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROTEIN FUNCTION; RESUSCITATION; REVIEW; SENSITIVITY AND SPECIFICITY; SHOCK; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; TROPONIN;

EID: 62749106742     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.03.022     Document Type: Review

References (82)

1. Filatov VL, Katrukha AG, Bulargina TV, Gusev NB. Troponin: structure, properties, and mechanism of functioning. Biochemistry (Moscow) 1999; 64: 969-985.
2. 2+ sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion. Am J Physiol Heart Circ Physiol 1981; 240: 704-708.
3. Mair J, Dworzak EA, Lechleitner P, Smidt J, Wagner I, Diensti F, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37: 845-852.
4. Katus HA, Remppis A, Neumann F, Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-912.
5. Ellis AK. Serum protein measurements and the diagnosis of acute myocardial infarction. Circulation 1991; 83: 1107-1109.
6. Chiu A, Chan WK, Cheng SH, Leung CK, Choi CH. Troponin-I, myoglobin, and mass concentration of creatine kinase-MB in acute myocardial infarction. Q J Med 1999; 92: 711-718.
7. Adams JE, Bodor GS, Roman VD, Delmez JA, Apple FS, Ladenson JH, et al. Cardiac troponin I a marker with high specificity for cardiac injury. Circulation 1993; 88: 101-106.
8. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 2004; 110: 588-636.
9. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333-1341.
10. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. The prognostic significance of admission troponin T concentrations in myocardial infarction. Circulation 1996; 94: 1291-1297.
11. Antman E, Milenko M, Tanasijevic J, Thompson B, Schactman M, McCabe CH, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-1349.
12. Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. Am J Cardiol 1999; 84: 1281-1286.
13. Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 1998; 98: 1853-1859.
14. Björklund E, Lindahl B, Johanson P, Jernberg T, Svensson AM, Venge P, et al. Admission troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction. Eur Heart J 2004; 25: 113-120.
15. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992; 327: 146-150.
16. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-1657.
17. Newby LK, Goldmann BU, Ohman EM. Troponin: an important prognostic marker and risk-stratification tool in non-ST segment elevation acute coronary syndromes. J Am Coll Cardiol 2003; 41 (4 Suppl S): s31-s36.
18. Lenderink T, Boersma E, Heeschen C, Vahanian A, de Boer MJ, Umans V, et al. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur Heart J 2003; 24: 77-85.
19. Heidenrich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001; 38: 478-485.
20. Dokainish H, Pillai M, Murphy SA, DiBattiste PM, Schweiger MJ, Lotfi A, et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndromes but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005; 45: 19-24.
21. Möckel M, Störk T, Heller G, Danne O, Darrelmann K, Eichstädt H, et al. Troponin T in patients with low grade or atypical angina: Identification of a high risk group for short- and long-term cardiovascular events. Eur Heart J 1998; 19: 1802-1807.
22. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113: 1958-1965.
23. Newby LK, Roe MT, Chen AY, Ohman EM, Christenson RH, Pollack CV, et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol 2006; 47: 312-318.
24. Kleiman NS, Lakkis N, Cannon CP, Murphy SA, DiBattiste PM, Demopoulos LA, et al. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 2002; 40: 1044-1050.
25. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-1887.
26. Kaul P, Newby LK, Fu YL, Hasselblad V, Mahaffey KW, Christenson RH, et al. Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. J Am Coll Cardiol 2003; 41: 371-380.
27. Nørgraad BL, Andersen K, Dellborg M, Abrahamsson P, Ravkilde J, Thygesen K, for the TRIM study group. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. J Am Coll Cardiol 1999; 33: 1519-1527.
28. Giannitsis E, Bardoff MM, Lehrke S, Wiegand U, Tölg R, Weidtmann B, et al. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation 2001; 104: 630-635.
29. Matetzky S, Sharir T, Domingo M, Noc M, Chyu KY, Kaul S, et al. Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation 2000; 102: 1611-1616.
30. Giannitsis E, Lehrke S, Wiegand UK, Kurowski V, Bardoff MM, Weidtmann B, et al. Risk stratification in patients with inferior acute myocardial infarction treated by percutaneous coronary interventions: The role of admission troponin T. Circulation 2000; 102: 2038-2044.
31. Kizer JR, Muttrej MR, Matthai WH, McConnell J, Nardone H, Sonel AF, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003; 24: 1314-1322.
32. Bonnemeier H, Wiegand UK, Giannitsis E, Schulenberg S, Hartmann F, Kurowski F, et al. Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T. Am Heart J 2003; 145: 484-492.
33. Heeschen C, Goldmann BU, Terres W, Hamm CW. Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status. Eur Heart J 2000; 21: 1159-1166.
34. Bonz AW, Lengenfelder B, Strotman J, Held S, Turschner O, Harre K, et al. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol 2001; 40: 662-668.
35. Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington RA, White HD, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the PARAGON-B troponin T substudy. Circulation 2001; 103: 2891-2896.
36. Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999; 341: 548.
37. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-1887.
38. Atar I, Korkmaz ME, Atar IA, Gulmez O, Ozin B, Bozbas H, et al. Effects of metoprolol therapy on cardiac troponin-I levels after elective percutaneous coronary interventions. Eur Heart J 2006; 27: 547-552.
39. Tünerir B, Colak Ö, Alata Ö, Beogul Y, Kural T, Aslan R. Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting. Ann Thorac Surg 1999; 68: 2173-2176.
40. Cantor WJ, Newby LK, Christenson RH, Tuttle RH, Hasselblad V, Armstrong PW, et al, for the SYMPHONY and 2nd SYMPHONY cardiac markers substudy investigators. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1738-1744.
41. Miller WL, Garratt KN, Burritt MF, Reeder GS, Jaffe AS. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest 2004; 125: 275-280.
42. Garbaz E, Lung B, Lefevre G, Makita Y, Farah B, Michaud P, et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 1999; 84: 515-518.
43. La Vecchia L, Bedogni F, Finocchi G, Mezzena G, Martini M, Sartori M, et al. Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting. Coron Artery Dis 1996; 7: 535-540.
44. Adams JE, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330: 670-674.
45. Hunt AC, Chow SL, Shiu MF, Chilton DC, Cummins B, Cummins P. Release of creatine kinase-MB and cardiac specific troponin I following percutaneous transluminal coronary angioplasty. Eur Heart J 1991; 12: 690-694.
46. Genser N, Mair J, Talasz H, Puschendorf B, Calzolari C, Larue C, et al. Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury. Clin Chem Acta 1997; 265: 207-217.
47. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998; 31: 241-251.
48. Haase J, Bayar R, Hackenbroch M, Störger H, Hofmann M, Schwarz CE, et al. Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interven Cardiol 2004; 17: 367-373.
49. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001; 103: 2780-2783.
50. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insight from cardiovascular magnetic resonance imaging. Circulation 2005; 111: 1027-1032.
51. Bolognese L, Ducci K, Angioli P, Falsini G, Liistro F, Baldassarre S, et al. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2004; 110: 1592-1597.
52. Fuchs S, Kornowski R, Mehran R, Lansky AJ, Satler LF, Pichard AD, et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000; 85: 1077-1082.
53. Okmen E, Cam N, Sanli A, Unal S, Tartan S, Vural M, et al. Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value. Angiology 2006; 57: 161-169.
54. Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 2005; 26: 1494-1498.
55. Miller WL, Garratt KN, Burritt MF, Lennon RJ, Reeder GS, Jaffe AS. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J 2006; 27: 1061-1069.
56. Thielmann M, Massoudy P, Neuhäser M, Knipp S, Kamler M, Piotrowski J, et al. Prognostic value of preoperative cardiac troponin I in patients with non-ST-segemnt elevation acute coronary syndromes undergoing coronary artery bypass surgery. Chest 2005; 128: 3526-3536.
57. Thielmann M, Massoudy P, Neuhäser M, Tsagakis K, Marggraf G, Kamler M, et al. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes. Circulation 2006; 114 (suppl I): I448-I453.
58. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum M, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score. JAMA 1992; 267: 2344-2348.
59. Lehrke S, Steen H, Sievers HH, Peters H, Opitz A, Bardoff MM, et al. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem 2004; 50: 1560-1567.
60. Thielmann M, Massoudy P, Schmermund A, Neuhäuser M, Marggraf G, Kamler K, et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 2005; 26: 2440-2447.
61. Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin I levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 2000; 69: 435-440.
62. Fellahi JL, Gue X, Richomme X, Monnier E, Guillon L, Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003; 99: 270-274.
63. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L, the FRISC II investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001; 38: 979-986.
64. Frey N, Dietz A, Kurowski V, Giannitsis E, Tolg R, Wiegand U, et al. Angiographic correlates of a positive troponin T test in patients with unstable angina. Crit Care Med 2001; 29: 1130-1136.
65. Jurlander B, Fahri ER, Banas JJ, Keany CM, Balu D, Grande P, et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. Am J Cardiol 2000; 85: 810-814.
66. deFilippi CR, Tocchi M, Parmar RJ, Rosanio S, Abreo G, Potter MA, et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol 2000; 35: 1827-1834.
67. Benamer H, Steg PG, Benessiano J, Vicaut C, Gaultier CJ, Aubry P, et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J 1999; 137: 815-820.
68. Heeschen C, van den Brand MJ, Hamm CW, Simoons ML. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation 1999; 100: 1509-1514.
69. Herrmann J, Haude M, Lerman A, Schulz R, Volbracht L, Ge J, et al. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation 2001; 103: 2339-2345.
70. Okamatsu K, Takano M, Skai S, Ishibashi F, Uemura R, Takano T, et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation 2004; 109: 465-470.
71. Wong GC, Morrow DA, Murphy S, Kraimer N, Pai R, James D, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Circulation 2002; 106: 202-207.
72. Ilva T, Eriksson S, Lund J, Porela P, Mustonen H, Pettersson K, et al. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept. Eur J Clin invest 2005; 35: 112-116.
73. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000; 102: 1221-1226.
74. Horwich TB, Patel JP, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108: 833-838.
75. Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose shemotherapy. Circulation 2004; 109: 2749-2754.
76. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088-3096.
77. Binder L, Pieske B, Olschewski M, Geibel A, Klostermann B, Reiner C, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112: 1573-1579.
78. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41: 2004-2009.
79. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus statement of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
80. Ishii J, Ozaki Y, Lu JC, Kitagawa F, Kuno T, Nakano T, et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 2005; 51: 1397-1404.
81. Alhadi HA, Fox KA. Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM 2004; 97: 187-198.
82. O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, et al. Prognostic utility of heart-type fatty acid-binding protein in patients with acute coronary syndromes. Circulation 2006; 114: 550-557.